Posts Tagged: acacia research


At the very beginning of the program Siegel, during his opening remarks, said: "At Acacia we are not in the litigation business, we are in the licensing business." I know that many will shrug or laugh at the comment, …

Continue Reading

Siegel: "I think this effort to destroy the value of intellectual property is a bigger wet towel on innovation. When startup companies, after they get their angel investing, go out to try and raise funds on round Bs and …

Continue Reading

Pitney Bowes and IBM to Collaborate on Hybrid Cloud Location Services ***** Patent Lawsuits Filed Over 3D Cinema Projection Technology ***** Microsoft and Dell Sign Patent Licensing Agreement ***** Tessera Technologies Ends Litigation Against Qualcomm ***** More Patents Tossed from Remote Control Patent …

Continue Reading

The month of January started off quite busy, which in all likelihood was as the result of deals and announcements either held over or that simply couldn't get done in the run up to closing out the year. There …

Continue Reading

Paul Ryan is a more common name than you might think. In the world of politics when one speaks of "Paul Ryan" they are talking about the Republican Congressman from Wisconsin who was Mitt Romney's running-mate and would-have-been Vice …

Continue Reading

Acacia announced that the Company’s Board of Directors has authorized a program for repurchasing shares of the Company’s outstanding common stock. The stock repurchase program will be put into effect immediately. Under the stock repurchase program, the …

Continue Reading

On November 8, 2012, Mylan Inc. (Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for …

Continue Reading

One of the newer prior art research studies currently underway at Article One Partners is one that relates to U.S. Patent No. 6,332,158, which relates to a system that assists user's in selecting desired domains. This study is of …

Continue Reading

This deal will give GSK exclusive rights to BENLYSTA, which is a human monoclonal antibody that inhibits B-cell activating factor (BAFF) approved for treatment of systemic lupus erythematosus. It is believed that BENLYSTA has blockbuster potential. According to Human …

Continue Reading

Merck and AstraZeneca Agree to Amend Partnership - Theradiag Acquires Innovative MicroRNA Technology Platform - 8x8 Sells Patent Family - MPEG LA Announces Call for Patents Essential HEVC - International Rectifier Enters Into Patent License Agreement - Acacia Subsidiary …

Continue Reading

The types of returns promised to investors and the types of benefits offered to participants are also quite different from garden-variety non-practicing entities, as are some of the tactics used in organizing the entities and in asserting the patents. …

Continue Reading

Acacia has long been considered by many to be the mother of all patent trolls. But are they really a patent troll? The term "patent troll" is one that is nearly impossible to define given the reality that one …

Continue Reading